Onkure Therapeutics Inc. Class AOKUR

13F holders, Q3 2024 (September 30)
1holders
$1.70avg. 13F price*

At the end of Q3 2024, 1 institutions reported holding Onkure Therapeutics Inc. Class A (OKUR) in their 13F filings. The largest holder was Catalyst Funds Management Pty Ltd ($5K).

Company
Onkure Therapeutics Inc. Class A
CUSIP
68277Q105
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080 Q3 2024: 1Q3 2024Q4 2024: 51Q4 2024Q1 2025: 47Q1 2025Q2 2025: 49Q2 2025Q3 2025: 42Q3 2025Q4 2025: 43Q4 2025Q1 2026: 51Q1 2026Q2 2026: 75Q2 2026

Total Exit/New Position Q3 2024

InstitutionsTotal Value
New Positions1$5K
Exits0$0

Ownership 1 holders

Catalyst Funds Management Pty Ltd 0.00% New 3,200 $5K

"% of holder's portfolio" is OKUR's weight in each manager's 13F, not the share of Onkure Therapeutics Inc. Class A the manager owns.